Citation Impact
Citing Papers
Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2
2011 Standout
Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus
2012
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations
2010
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Pharmacotherapy of type 2 diabetes: An update
2017
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
2011
Biologic actions and therapeutic potential of the proglucagon-derived peptides
2005
The Cardiovascular Biology of Glucagon-like Peptide-1
2016
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes
2016
Microbial tryptophan catabolites in health and disease
2018 Standout
Glucagon-Like Peptide-1 Limits Myocardial Stunning following Brief Coronary Occlusion and Reperfusion in Conscious Canines
2004
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
The biology of incretin hormones
2006 Standout
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
2011
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
2010
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects
2009
Biology of Incretins: GLP-1 and GIP
2007 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Postconditioning and protection from reperfusion injury: where do we stand? * Position Paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology
2010
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Diabetes and Mortality Following Acute Coronary Syndromes
2007
How were new medicines discovered?
2011 Standout
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
The Physiology of Glucagon-like Peptide 1
2007 Standout
Preconditioning and postconditioning: Underlying mechanisms and clinical application
2008
Myocardial Reperfusion Injury
2007 Standout
Peptide therapeutics: current status and future directions
2014 Standout
A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes
2010
Pathogenesis of Myocardial Ischemia-Reperfusion Injury and Rationale for Therapy
2010
Approach to diabetes management in patients with CVD
2015
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
G protein-coupled receptors as targets for anti-diabetic therapeutics
2016
Type 2 diabetes mellitus
2015 Standout
Cardiovascular Effects of Glucagonlike peptide–1 Agonists
2011
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
2014
Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
2010
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Realizing the clinical potential of ischemic preconditioning and postconditioning
2005
The therapeutic potential of ischemic conditioning: an update
2011
Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat
2013
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
2011
Mitochondrial Pathways, Permeability Transition Pore, and Redox Signaling in Cardioprotection: Therapeutic Implications
2012
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Fluorine in medicinal chemistry
2007 Standout
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Hyperglycemia in Acute Ischemic Stroke: A Vascular Perspective
2006
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Cardiovascular Biology of the Incretin System
2012
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
2017
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options
2010
Diabetic Cardiomyopathy
2018 Standout
Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
2010
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association
2016
Diabetic Kidney Disease
2017 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Mechanistic Features Associated With Improvement in Mitral Regurgitation After Cardiac Resynchronization Therapy and Their Relation to Long-Term Patient Outcome
2013
Cardiovascular effects of the DPP-4 inhibitors
2012
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)‐TIMI 53 trial
2013
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
New Drugs for the Treatment of Diabetes
2008
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Liraglutide: a once-daily GLP-1 analogue for the treatment of Type 2 diabetes mellitus
2007
Cardiovascular Actions of Incretin-Based Therapies
2014
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
2009 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Works of Glen Miske being referenced
Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy
2010
Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion
2004